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Conclusions. IMRT using noncoplanar beams is a good solution for radiotherapy treatment of patients with bilateral prosthetic
hip.
http://dx.doi.org/10.1016/j.rpor.2013.03.510
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Introduction. Intense Modulated Radiotherapy (IMRT) and Volume Modulated Arc Therapy (VMAT) have been recently introduced
in prostate cancer clinical practice. Both treatments allow hypofractionation.
Objective. To report technical aspects, clinical results and side effects in our series of patients treated with IMRT or VMAT with
hypofractionation.
Patients and methods. In CROASA and ONCOSUR between January 2010 and December 2012 we have treated 70 patients with
prostate cancer and a mean age of 65.92 years (48–77). We have evaluated analytical, clinical, therapeutic data and acute toxicity.
Results. With a mean initial PSA of 11.6ng/ml (2.6–43.29), patients had a localized stage (pT1c=33.3%; pT2a-c = 52.1% pT3a-
c = 14.3%; N0=100%). According to theNCCN, low-risk patientswere 24.6%, 47.8% intermediate risk and high risk 24.6%. The 27.5%
of patients were referred due to biochemical failure, 8.7% for adjuvant therapy after surgery, and 63.8% for radical treatment. The
39.1% of patients received hormone therapy. Patients were treated with IMRT (55.07%) or VMAT (44.9%) plus a cone beam for IGRT
before each session. The mean dose prescription was 66Gy (60–66) administrated in 3Gy/fraction during 20 or 22 days. Acute
toxicity was scored. No patient showed G II–III rectal toxicity and only a 13% of acute GII bladder toxicity was reported. With a
mean follow up of 9.18 months (1–24), the 91.2% stay alive without biochemical failure with a mean PSA control of 0.59ng/ml
(0–7.86).
Conclusion. IMRT or VMAT in combination with the accuracy of IGRT, allow a high dose per fraction with an improvement in
radiobiological effect and quality of life.
http://dx.doi.org/10.1016/j.rpor.2013.03.511
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Introduction. Desmoplasic small round cell tumors (DSRCTs) are rare aggressive neoplasms that often appear with large symp-
tomatic intraabdominal masses. The typical presentation is a young male with abdominal symptoms and frequently there are
metastasis at the diagnosis. The prognosis is usually poor. Despite the diversities in treatment modalities, the best results have
been obtained with radical surgery, chemotherapy and adjuvant radiotherapy.
Case report. We report a 33 year-old male who went to the emergency room several times complaining a prostatic syn-
drome and pain in the left testicle. Physical examination revealed no abnormalities except for a painful large prostate with
increased consistency. The hemogram and biochemistry were normal. PSA (0.66ng/dl). The images showed enlarge prostatic
mass 7.3 cm×5 cm×4 cm in contact with seminal vesicles. The biopsy of prostate revealed desmoplastic small round cell tumor
(DSRCT). Taken these conclusions, the treatment agreed by a multidisplinary group was chemotherapy, surgical debulking and
radiotherapy. Four months after the treatment was ﬁnished, the multiple lung metastasis appeared on a CT-scan, without
pelvic-disease. 4 lines of QT were used for metastatic disease without success. 1 year and 4 months later the patient died.
Discussion. DSRCT is an aggressive tumor without a clear understanding of the natural history. About 200 cases have been
reported to literature. Due to high diversity in treatment options and the low incidence, there is no clear consensus on the best
management of DSRCT. This case proves the efﬁcacy of the local treatment. Therefore adjuvant radiotherapy should be taken
into account in the multimodal therapy.
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